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ABSTRACT 
 
Mucormycosis usually occurs in immunocompromised patients with uncontrolled diabetes mellitus, hematologic 
malignancies etc. These fungi show a predilection for arterial invasion, causing widespread emboli and necrosis of 
contiguous tissues. Here, we present a case report of Mucormycosis in an immunocompromised diabetic patient and 
also the review of the literature. 
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Introduction 
Fungal spores are usually present in soil, manure etc 
and humans are usually exposed to them [1]. Mucosal 
and pulmonary defence mechanisms prevent these 
fungi to inhabitate humans and cause harmful effects. 
But in patients with suppressed immunity, these fungi 
can cause life threatening effects, hence are called as 
opportunistic infections [1,2]. Mucormycosis is a lethal 
disease caused by Mucorales which has about 50 to 
100% mortality rates [3].  The first case of 
mucormycosis was reported by Paultauf in 1885[1].The 
mode of infection of this deadly infection may be by 
inhalation, ingestion or contamination of traumatized 
mucosa like ulcer or extraction socket by fungal spores 
[2,4]. We present a rare case report of mucormycosis 
affecting the oral cavity in a diabetic patient and its 
literature review. 
 
Case Report 
A 56 year old male patient reported with a chief 
complaint of pus discharge from the upper left back  
_______________________________ 
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region of the jaw since three months. Pain was 
continuous and mild in nature. Initially he had a 
swelling which was small in size and gradually 
increased and localized to discharge pus. His medical 
history revealed that he is a known diabetic since more 
than 10 years and was under medication. Since last one 
year he was taking medication irregularly, and stopped 
taking medication since last 3 months after taking 
advise of a local non registered practitioner. Past dental 
history revealed that one year back he visited a local 
dentist for swelling and pain in upper posterior teeth, 
which were loose. He got 23 to 27 teeth extracted in 
one visit. Personal history revealed that he is a chronic 
smoker (15 to 20 bidis per day since 15 years).Extra-
oral examination revealed facial asymmetry with 
swelling over left face. Left submandibular lymph node 
was palpable. Intra-oral examination revealed a solitary 
exposed necrotic area of about 3x2cms over left 
gingival region from 23 to 27 region (Fig 1). The 
necrotic area extended medially up to 23, laterally till 
the gingival margins of 27.  Lesional surface was 
rough, firm in consistency and tender. There was pus 
discharge and severe halitosis. Extracted sockets of 23 
to 27 were dry, brownish to blackish, denuded and 
necrotic. Blood investigations showed glucose levels 
were beyond normal values (300mg/dl), raised ESR 
(62 mm/hr). Urinary dextrose strip was +++ and 
urinary ketone bodies-positive. With a provisional 
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diagnosis of chronic granulomatous infection, 
potassium hydroxide smears of scrapings were done 
and it showed aseptate fungal hyphae. Then incisional 
biopsy was carried out involving lesional area along 
with adjacent normal tissue. Hematoxylin and Eosin (H 
and E) stained sections at focal areas revealed few 
broad aseptate fungi of non uniform diameter (Fig.2). 
Special stains with PAS (Periodic Acid Schiff) was 
carried out. PAS staining was positive showing broad 
aseptate fungi of magenta color (Fig.3). A diagnosis of 
Mucormycosis was given. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1:Intra-oral view Fig 2: H & E photomicrograph showing broad 
aseptate fungi in intertrabecular areas 
 
 
Fig 3: PAS stain showing broad aseptate fungi of magenta color 
 
The patient was admitted and given insulin injections for control of blood glucose levels after taking opinion of 
physician. Surgical debridement was done. Amphotericin B (intravenously 1mg/kg/day) was given and patient was 
discharged after one week. The patient is recalled for follow up every month and is under physician’s observation. 
 
Discussion 
 
Mucormycosis is a grave opportunistic infection 
caused by fungi of order mucorales[1].It shows 
pathognomic histologic features, the fungi appears 
typically as broad, irregularly shaped with nonseptate 
hyphae having right angled branches[1,5]. It is 
opportunistic fungal infection like candidiasis and 
Aspergillosis and is seen mainly in 
immunocompromised individuals with uncontrolled 
diabetes, leukemia, burns patients, organ 
transplantation patients, cancer drugs [6].These fungi 
inhabitate nasal mucosa, lungs (mode of infection 
being inhalation) and gastrointestinal tract (mode of 
infection being ingestion)[6,7].Clinically 4 variants of 
mucormycosis occur, rhinocerebral (most common), 
pulmonary, gastrointestinal, and disseminated. 
Rhinocerebral form is of two subtypes. 
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Rhinoorbitocerebral type considered as most fatal, 
which involves ophthalmic and internal carotid arteries, 
Rhinomaxillary form, which involves sphenopalatine 
and greater palatine arteries. Our case is 
Rhinomaxillary type. Overall prevalence of this 
subtype in diabetics is only about 0.15% [1,2,8] 
Mucormycosis shows a predilection for arteries, where 
they proliferate and as a consequence causes arterial 
thrombosis. Later they invade veins and lymphatics 
also thereby leading to necrosis of involved hard and 
soft tissues [8,9]Literature review showed that the 
average age of the patients was 38.8 years, whereas our 
patient is 56 year old[10]. The lesions that can be 
considered in differential diagnosis clinically are 
Wegener’s granulomatosis, tuberculosis, squamous cell 
carcinoma, malignant salivary gland tumor and tertiary 
syphilis [1,6].H and E sections and special stains of this 
fungal infection shows broad asepate fungi that branch 
at right angles, which was the same in our case[6-8]. 
Treatment protocol should be initial surgical 
debridement of the involved area followed by 
administration of antifungal drugs intravenously 
(Amphotericin B 11.5 mg/kg daily). For successful 
treatment, early diagnosis, proper treatment and 
correction of underlying cause are very essential. 
Prognosis depends on cerebral involvement. Survival 
rates have been shown to be less than 20% in cerebral 
cases. Cases without cerebral involvement show 50 to 
80% survival rates[11,12]Our patient survived because 
of early diagnosis and prompt medical and surgical 
treatment. 
 
Conclusion 
 
Mucormycosis is a fatal infection in diabetic patients 
with a high mortality rate. Physicians, dentists should 
always keep in mind of this fatal infection in immune- 
compromized patients. An early diagnosis, combined 
with medical and surgical treatments, will reduce the 
mortality rate of this dreadful infection. 
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